{"name":"MYLAN SPECIALITY LP","slug":"mylan-speciality-lp","ticker":"","exchange":"","domain":"mylanspecialitylp.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharmaceuticals","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"1959-01-01","label":"Soma first approved","drug":"Soma","drugSlug":"carisoprodol","type":"approval","sentiment":"positive"},{"date":"1993-01-01","label":"Felbatol first approved","drug":"Felbatol","drugSlug":"felbamate","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Soma","genericName":"CARISOPRODOL","slug":"carisoprodol","indication":"Backache","status":"marketed"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Felbatol","genericName":"FELBAMATE","slug":"felbamate","indication":"Epilepsy","status":"marketed"}]}],"pipeline":[{"name":"Soma","genericName":"CARISOPRODOL","slug":"carisoprodol","phase":"marketed","mechanism":"Carisoprodol's mechanism for relieving acute musculoskeletal pain is unclear, but it involves altered interneuronal activity in the spinal cord and brain.","indications":["Backache","Muscle Spasm with Pain","Spasticity"],"catalyst":""},{"name":"Felbatol","genericName":"FELBAMATE","slug":"felbamate","phase":"marketed","mechanism":"Felbamate's exact mechanism is unknown, but it shows anticonvulsant activity in various animal models and interacts with the NMDA receptor-ionophore complex.","indications":["Epilepsy","Lennox-Gastaut syndrome","Simple partial seizure"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}